Organization | Unipharm, Inc.

Unipharm, Inc. Report issue

For profit Phase 2 Phase 4

Founded: New York MD United States (1992)

Status: No NME R&D (1992)

Organization Overview

First Clinical Trial

2005

NCT00422617

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. | UNIPHARMA. Universal Pharmaceutical Industries

Active Ingredients

Drugs in Phase 4 Trials (5)

acetaminophen (tylenol) (1 trial)

clarithromycin (biaxin) (1 trial)

ferrous sulfate (1 trial)

Iron protein acetyl aspartate (1 trial)

levofloxacin (levaquin) (1 trial)

Drugs in Phase 2 Trials (2)

chloroquine (1 trial)

sodium l-triiodothyronine (1 trial)

Drugs in Other Trials (3)

alefacept (Amevive) (1 trial)

chondroitin (1 trial)

glucosamine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Communicable Diseases (Phase 2)

Deficiency Diseases (Phase 4)

Fever (Phase 4)

Infections (Phase 4)

Pneumonia (Phase 2)

Pneumonia, Viral (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 7
# of Trial APIs: 10